Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) 2022-12, Vol.12 (12), p.168-168, Article 168
Main Authors: Mohyuddin, Ghulam Rehman, Chakraborty, Rajshekhar, Calip, Gregory S., Ascha, Mustafa S., Wang, Xiaoliang, Rubinstein, Samuel M., Tuchman, Sascha, Costa, Luciano, Haaland, Benjamin, Giri, Smith, Mian, Hira, Fonseca, Rafael, Sborov, Douglas
Format: Article
Language:English
Subjects:
631/67/1990/804
692/699/1541/1990/804
ADP-ribosyl Cyclase 1
Antineoplastic Combined Chemotherapy Protocols
Biomedical and Life Sciences
Biomedicine
Cancer Research
Correspondence
Hematology
Humans
Multiple Myeloma - diagnosis
Multiple Myeloma - drug therapy
Neoplasms, Plasma Cell
Oncology
Prognosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2044-5385
2044-5385
DOI:10.1038/s41408-022-00769-4